Skip to content

Bovine-derived Xenograft With or Without L-PRF for Alveolar Ridge Preservation After Tooth Extraction: a Randomized Controlled Trial

Bovine-derived Xenograft (Bio-Oss Collagen) With or Without Leukocyte-platelet Rich Fibrin (L-PRF) for Alveolar Ridge Preservation After Tooth Extraction: a Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06172114
Enrollment
34
Registered
2023-12-15
Start date
2024-04-20
Completion date
2025-12-09
Last updated
2024-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Regeneration, Dental Implants, Tooth Extraction

Brief summary

The study is prospective randomized clinical trial that aims to evaluate the adjunctive use of L-PRF in promoting the desired vascularization and bone fill in small and large defects following tooth extraction and report on the long-term implant and patient outcomes

Interventions

PROCEDUREAlveolar ridge preservation using sticky bone

In the test group the xenograft will be mixed in with the L-PRF then placed into the socket.

Sponsors

Mohammed Bin Rashid University of Medicine and Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aged 18 or over. * Require extraction of anterior or posterior single tooth due to caries, endodontic and prosthetic complications. * The tooth that requires extraction is bordered by two teeth. * Controlled oral hygiene (full-mouth plaque and bleeding scores ≤ 25% at baseline). * Good compliance and commitment to attend follow-up review appointments. * Willing to provide informed consent.

Exclusion criteria

* Localised / generalised periodontitis. * Presence of acute periapical lesion. * Bone metabolic disease and/or taking medications that affect bone metabolism. * Long term use of non-steroidal anti-inflammatory medications. * History of malignancy, radiotherapy or chemotherapy. * Pregnant or lactating women. * Severe bruxism or parafunctional habits. * Large occlusal discrepancies.

Design outcomes

Primary

MeasureTime frameDescription
Implant survival / success rate will be assessed clinically after one year of implant restoration and annually up to three years.2 years
Patient postoperative experience will be assessed using visual analogue scale during the first week following tooth extraction and ridge preservation.2 yearsReporting a score will be done using the pain visual analogue scale. Minimum value is 0 which is no pain and maximum value is 10 which is the worst pain ever experienced.

Secondary

MeasureTime frame
Changes in peri-implant marginal bone level will be assessed at implant placement (baseline) and after one year of implant restoration and annually up to two years using standardized peri-apical radiograph.2 years
Changes in width and height of alveolar ridge will be assessed at the time of tooth extraction and ridge preservation, six months (prior to implant placement) and annually up to two years using cone beam computed tomography (CBCT).2 years
Biological complications (i.e. peri-implant diseases) will be assessed clinically using periodontal probe after one year of implant restoration and annually up to two years.2 years
Soft tissue levels (midbuccal marginal tissue level changes, interproximal papilla level changes and changes in width of keratinised tissue) will be assessed at implant placement (baseline), at 1 year and at 2 years2 years
Need for additional bone augmentation will only be assessed at the time of implant placement by recording the use of bone graft (if required) in the clinical notes.2 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026